Aβ-Cu(Ⅱ)神经毒性及Cu(Ⅱ)螯合剂的缓解机制

被引:2
作者
徐魏
黄汉昌
姜招峰
机构
[1] 北京联合大学应用文理学院
[2] 北京联合大学生物活性物质与功能食品北京市重点实验室
关键词
Aβ-Cu(Ⅱ)复合物; 氯碘羟喹; 姜黄素; DP-109;
D O I
10.13488/j.smhx.2009.04.030
中图分类号
R749.16 [];
学科分类号
100203 ;
摘要
AD患者脑内大量沉积的过渡态金属离子Cu(Ⅱ)能与β-淀粉样蛋白(Aβ)络合形成Aβ-Cu(Ⅱ)复合物,Aβ-Cu(Ⅱ)复合物在脑内聚集形成老年斑,进而对神经元造成损伤被认为是阿尔茨海默病致病机理的关键环节。用于阿尔茨海默病治疗的Cu(Ⅱ)螯合剂是一类能自由透过血脑屏障,络合AD患者脑内过量沉积的Cu(Ⅱ),从而溶解老年斑和缓解神经损伤的小分子活性物质。Cu(Ⅱ)螯合剂是近年来AD治疗策略的研究热点之一。文章综述了Cu(Ⅱ)诱导的Aβ集聚和氧化损伤毒性,总结了几种缓解Aβ-Cu(Ⅱ)复合物神经毒性的Cu(Ⅱ)螯合剂,并对Cu(Ⅱ)螯合剂作为AD治疗药物的研究前景作了展望。
引用
收藏
页码:485 / 489
页数:5
相关论文
共 6 条
[1]  
Accumulated Amyloid-β Peptide andHyperphosphorylated Tau Protein: Relationship and Links in Alzheimer'sDisease[J] . Han-Chang Huang,Zhao-Feng Jiang.Journal of Alzheimer’s Disease . 2009 (1)
[2]  
Glia maturation factor modulates β-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage[J] . Asgar Zaheer,Smita Zaheer,Ramasamy Thangavel,Yanghong Wu,Shailendra K. Sahu,Baoli Yang.Brain Research . 2008
[3]   Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models [J].
Baum, L ;
Ng, A .
JOURNAL OF ALZHEIMERS DISEASE, 2004, 6 (04) :367-377
[4]   The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human β-amyloid precursor protein transgenic mice [J].
Lee, JY ;
Friedman, JE ;
Angel, I ;
Kozak, A ;
Koh, JY .
NEUROBIOLOGY OF AGING, 2004, 25 (10) :1315-1321
[5]   Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice [J].
Cherny, RA ;
Atwood, CS ;
Xilinas, ME ;
Gray, DN ;
Jones, WD ;
McLean, CA ;
Barnham, KJ ;
Volitakis, I ;
Fraser, FW ;
Kim, YS ;
Huang, XD ;
Goldstein, LE ;
Moir, RD ;
Lim, JT ;
Beyreuther, K ;
Zheng, H ;
Tanzi, RE ;
Masters, CL ;
Bush, AI .
NEURON, 2001, 30 (03) :665-676
[6]  
Copper, iron and zinc in Alzheimer's disease senile plaques[J] . M.A Lovell,J.D Robertson,W.J Teesdale,J.L Campbell,W.R Markesbery.Journal of the Neurological Sciences . 1998 (1)